Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001246010 | SCV001419337 | uncertain significance | Congenital myasthenic syndrome 4A | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with histidine, which is basic and polar, at codon 475 of the CHRNE protein (p.Leu475His). This variant is present in population databases (rs764935677, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 970439). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001835254 | SCV002093366 | uncertain significance | Congenital myasthenic syndrome | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004548098 | SCV004727182 | uncertain significance | CHRNE-related disorder | 2023-10-30 | no assertion criteria provided | clinical testing | The CHRNE c.1424T>A variant is predicted to result in the amino acid substitution p.Leu475His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-4802089-A-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |